NCT03969446 2026-03-05Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or RefractoryCity of Hope Medical CenterPhase 1 Recruiting54 enrolled
NCT06863402 2025-12-23Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma SubtypeRoswell Park Cancer InstitutePhase 2 Recruiting32 enrolled
NCT03219450 2025-05-22A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.Dana-Farber Cancer InstitutePhase 1 Recruiting15 enrolled